-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Maintains Neutral on Select Medical Hldgs, Lowers Price Target to $14

Benzinga·08/04/2025 13:49:00
Listen to the news
UBS analyst A.J. Rice maintains Select Medical Hldgs (NYSE:SEM) with a Neutral and lowers the price target from $15 to $14.